tradingkey.logo

Japan's Nikkei ends lower as court battle over US tariffs weighs

ReutersMay 30, 2025 6:56 AM

- Japan's Nikkei share price average ended lower on Friday, weighed down by uncertainty surrounding a court battle about U.S. President Donald Trump's tariffs as well as a stronger yen which hurt exporters.

The Nikkei index .N225 fell 1.22% to close at 37,965.1, having ended the previous trading session at its highest point in more than two weeks. It rose 2.17% over the week.

The broader Topix .TOPX fell 0.37% to 2,801.57 and rose 2.41% for the week.

"Japanese shares rose yesterday on expectations that the impact of Trump's tariffs on the global economy would be eased, but that positive mood was erased overnight," said market analyst Shuutarou Yasuda at Tokai Tokyo Intelligence Laboratory.

A federal appeals court temporarily reinstated the most sweeping of Trump's tariffs on Thursday, a day after a trade court ruled that the president had exceeded his authority in imposing the duties and ordered an immediate block on them.

The U.S. dollar fell following the news, pushing the yen as high as 143.45 on Friday.

Strong inflation data on Friday for Japan's capital also helped the yen to strengthen, strategists said.

Automakers fell, with Nissan Motor 7201.T and Honda Motor 7267.T slipping 3.13% and 1.87%, respectively. Toyota Motor 7203.T erased early loss to end 1.26% higher.

A stronger yen typically weighs on exporter shares by reducing the value of overseas earnings when converted back into Japanese currency.

Chip-related shares fell, with Advantest 6857.T and Tokyo Electron 8035.T down 3.61% and 4.76% respectively, to drag on the Nikkei the most.

Bucking the trend, drugmakers rose, with Otsuka Holdings 4578.T jumping 6.82% to provide the biggest support for the Nikkei.

Of more than 1,600 stocks trading on the Tokyo Stock Exchange's prime market, 57% rose, 38% fell and 3% were flat.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI